Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo
NCT01890538
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
94
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Vertigo
Interventions
DRUG:
Administration of 100 mg dimenhydrinate intravenous
DRUG:
2 g piracetam intravenous
Sponsor
Kocaeli University